Skip to main content
. 2020 Sep 30;10:16142. doi: 10.1038/s41598-020-72852-4

Figure 3.

Figure 3

Performance comparison of the metabolic biomarker panels and sFlt-1/PlGF ratio for discriminating preeclampsia from non-preeclampsia in the at-delivery cohort. (A) Receiver operating characteristic (ROC) curve analysis. The same metabolic biomarker derived from the mid-trimester cohort study is re-formulated for at-delivery cohort using binary logistic regression analysis (biomarker panel1). New biomarker panel was generated based metabolite set determined from at-delivery cohort study (biomarker panel2). (B) Validation based on permutation test with 100 time-random sampling (C) Summarized features of ROC curve analysis of the tested models.